Skip to content
TrialScanner

NCT03490942

Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses

Phase 2TerminatedXERSLead

Registry record

Lead sponsor
Xeris Pharmaceuticals
Conditions
Hypoglycemia Unawareness; Diabetes Mellitus, Type 1
Primary completion
Nov 4, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03490942 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03490942: Glucagon Infusion in T1D... | TrialScanner